Ellevest Inc’s Ovid Therapeutics OVID Stock Holding History

Ellevest Inc’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-53	Closed	–	–	1581
2021 Q3	$0	Hold	53	–	–	﹤0.01%	1526
2021 Q2	$0	Buy	+53	New	+$209	﹤0.01%	1371
2021 Q1	–	Sell	-1	Closed	–	–	1328
2020 Q4	$0	Buy	+1	New	+$5	﹤0.01%	1308

Other funds holding OVID

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ellevest Inc's OVID Position: Q4 2021 in Review

Ellevest Inc sold out of Ovid Therapeutics (OVID) in Q4 2021, closing a stake of 53 shares.

Ellevest Inc first reported a position in OVID in Q4 2020 and held it in 3 quarters. The position peaked at $0 in Q3 2021. 67 funds tracked by Wall St. Rank hold OVID as of Q4 2021.

Ellevest Inc reported no remaining Ovid Therapeutics position as of Q4 2021 after selling out during the quarter.
Ellevest Inc sold 53 Ovid Therapeutics shares in Q4 2021.
Ellevest Inc first reported a position in Ovid Therapeutics in Q4 2020 and held it in 3 quarters.
Ellevest Inc's Ovid Therapeutics position peaked at $0 in Q3 2021.
67 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q4 2021.

Based on Ellevest Inc's 13F filing for Q4 2021, filed 24 Jan 2022.